1. |
Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med, 2005, 353(17):1793-1801.
|
2. |
Peng SY, Chen WJ, Lai PL, et al. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma:Significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer, 2004, 112(1):44-50.
|
3. |
Xie C, Wu J, Yun J, et al. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One, 2013, 8(5):e64235.
|
4. |
Lee SG, Su ZZ, Emdad L, Sarkar D et al. Astrocyte elevated gene-activates cell survival pathways through PI3K-Akt signaling. Oncogene, 2008, 27(8):1114-1121.
|
5. |
Kang DC, Su ZZ, Sarkar D, et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene, 2005, 353(1):8-15.
|
6. |
Yoo BK, Emdad L, Su ZZ, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest, 2009, 119(3):465-477.
|
7. |
Liu Y, Su ZW, Li G, et al. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma. Int J Cancer, 2013, 133(3):671-679.
|
8. |
Liu G, Huang X, Cui X, et al. High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma. Med Oncol, 2013, 30(3):537.
|
9. |
Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell, 2004, 5(4):365-374.
|
10. |
Huang W, Yang L, Liang S, et al. AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers. Dig Dis Sci, 2013, 58(10):2873-2880.
|
11. |
Yao Y, Gu X, Liu H, et al. Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. Br J Cancer, 2014, 111(2):355-364.
|
12. |
Nikpour M, Emadi-Baygi M, Fischer U, et al. MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer. Urol Oncol, 2014, 32(5):670-677.
|
13. |
Yu C, Liu Y, Tan H, et al. Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition. Cancer Lett, 2014, 343(2):258-267.
|
14. |
Hui AB, Bruce JP, Alajez NM, et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res, 2011, 17(24):7539-7550.
|
15. |
Zhu K, Dai Z, Pan Q, et al. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res, 2011, 17(23):7294-7302.
|
16. |
Sarkar D. AEG-1/MTDH/LYRIC in liver cancer. Adv Cancer Res, 2013, 120:193-221.
|
17. |
Eissa LA, Eisa NH, Ebrahim M, et al. Nitric oxide is a potential diagnostic marker for hepatocellular carcinoma. Sci Pharm, 2013, 81(3):763-775.
|
18. |
Chan SL, Mo F, Johnson PJ, et al. Performance of serumα-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. HPB (Oxford), 2014, 16(4):366-372.
|
19. |
Gopal P, Yopp AC, Waljee AK, et al. Factors that affect accuracy ofα-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol, 2014, 12(5):870-877.
|
20. |
Bhat M, Hassanain M, Simoneau E, et al. Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma. Curr Oncol, 2013, 20(5):265-272.
|
21. |
Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology, 2005, 42(5):1208-1236.
|
22. |
Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int, 2010, 4(2):439-474.
|
23. |
Fan LF, Zhao WC, Yang N, et al. Alpha-fetoprotein:the predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resection. Hepatogastroenterology, 2013, 60(124):825-836.
|
24. |
Singal AG, Conjeevaram HS, Volk ML, et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev, 2012, 21(5):793-799.
|